Abigail Donovan, MD, discusses what brexpiprazole can do for treating schizophrenia in older children.
Contemporary Pediatrics sat down with Abigail Donovan, MD, assistant professor of psychiatry at Massachusetts General Hospital in Boston to discuss brexpiprazole, which recently received a supplemental new drug application from the US Fod and Drug Administration for use in patients aged 13 to 17 years. She discussed what it brings to the table, the adverse effects it can cause, and who is likely to prescribe it.
DB-OTO demonstrates improved hearing in 10 of 11 children with profound genetic hearing loss
February 24th 2025Updated data from the phase 1/2 CHORD trial in 12 children with profound genetic hearing loss were presented at the Association for Research in Otolaryngology’s 48th Annual MidWinter Meeting.